Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Aug 2026 for Arcutis Biotherapeutics, Inc., €40k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Patrick Burnett: trading record in brief
Patrick Burnett discloses dealings in Arcutis Biotherapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 3 August 2026 to 19 August 2026, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 19 August 2026, the filings show a transaction worth €40k in Arcutis Biotherapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Patrick Burnett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,697 shares@ US$27.00CommonSEC144:0001628280-26-057973
15,000 shares@ US$26.52160.012% mcap94.1% of flowCommonSEC144:0001628280-26-055797
955 shares@ US$26.11680.0008% mcap100.0% of flowCommonSEC144:0001628280-26-051952
3 of 3 declarations
